Business Responsibility and Sustainability Report

Overview

The report presents Sun Pharma's FY2024-25 sustainability performance, including a 35% absolute Scope 1 and Scope 2 emissions-reduction target by 2030 and a 24.69% reduction achieved against the 2020 baseline. Renewable energy represented 49.77% of the energy mix, while water consumption was reduced by 31.70%, exceeding the 2025 target. The company also reports ₹ 508.34 million in CSR spending and extensive community-health, education, water and rural-development initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services